Immunic: Data Shows Favorable Pharmacokinetic Profile For IMU-856 In Single, 14-Day Multiple Dosing

Immunic, Inc. (IMUX) reported positive unblinded safety, tolerability and pharmacokinetic results from single and multiple ascending dose parts of phase 1 trial of IMU-856 in healthy human subjects. IMU-856 is a small molecule modulator targeting restoration of intestinal barrier function and regeneration of bowel epithelium, in healthy human subjects.

"In line with our preclinical findings, the data did not show any drug-related adverse events or laboratory abnormalities that would require further investigation. In addition, the pharmacokinetic results indicate that IMU-856 is well suited for a once-daily oral administration," said Andreas Muehler, Chief Medical Officer of Immunic.

The company noted that the ongoing part C of the phase 1 program includes a double-blind, randomized, placebo-controlled trial designed to assess the safety and tolerability of IMU-856 in patients with celiac disease during periods of gluten-free diet and gluten challenge.

For More Such Health News, visit rttnews.com.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Ride-hailing and delivery platform Uber Technologies, Inc. reported Wednesday weak profit in its fourth quarter, while adjusted EBITDA surged from last year with strong revenue growth above market view. Gross bookings increased and the company projects higher gross bookings in the first quarter. Nelson Chai, CFO, said the company significantly exceeded profitability outlook in 2022, ... Societe Generale Group reported Wednesday a weak profit in its fourth quarter, despite higher net banking income. Further, the French Financial services major proposed a dividend and around 440 million euros share buyback program. The company also confirmed fiscal 2025 financial targets. City of Industry, California-based Titans Global Inc. is recalling certain JSJ branded cakes citing potential to contain undeclared eggs, a known allergen, the U.S. Food and Drug Administration said. The recall involves its 95g packages of JSJ Chocolate Cake, JSJ ZSR Cake, and JSJ DMC Leaf Cake food treats.
Follow RTT